Sanofi Pasteur, the vaccines division of Sanofi, announced today the launch of Shan5, its paediatric pentavalent vaccine developed and manufactured by its affiliate Shantha Biotechnic in India.
The vaccine received prequalification status from the World Health Organisation (WHO) in April 2014.
“A significant number of babies born every year in India do not have access to modern vaccination programmes. The launch of Shan 5 in India means that 27 million babies born annually in India will have access to vaccination to protect from five potentially deadly diseases. By launching the vaccine Shantha will be contributing to filling this immunisation gap for the benefit of babies and their parents,” Harish Iyer, CEO of Hyderabad-based Shantha said.
The WHO prequalification helps secure the supply of pentavalent combination vaccines in over 50 emerging and low-income countries, according to the company.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.